Trivalent Salmonella Conjugate Vaccine (TSCV)
Clinical trial NCT05784701 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05784701
- Sponsor
- University of Maryland, Baltimore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2027-01-05
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.